In the North American medical devices industry, there were 54 M&A deals announced in Q3 2023, worth a total value of $1.5bn, according to GlobalData’s Deals Database. The $850m acquisition of Relievant MedSystems by Boston Scientific was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q3 2023 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
Smarter leaders trust GlobalData
In value terms, M&A activity in North America decreased by 70% in Q3 2023 compared with the previous quarter’s total of $5bn and fell by 89% as compared to Q3 2022. Related deal volume decreased by 18% in Q3 2023 versus the previous quarter and was 28% lower than in Q3 2022.
The top-ranked financial advisors supporting these M&A deals in North America in Q3 2023 were Piper Sandler Companies; Bank of America; UBS Group with 9, 4, 4 deals respectively.
The top-ranked legal advisors supporting these M&A deals in North America Q3 2023 were White & Case; Baker & McKenzie; Goodwin Procter with 5, 4, 4 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q3 2023 – Thematic Intelligence, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.
